Loading
No insider purchase over the last 90 days. The latest, by TSOI HOI SHAN, was filed 13 Jul 2026.
United Laboratories International Holdings Ltd., The is a listed company. Filings by its managers are published through HKEX. In the past year (19 October 2025 to 19 October 2026), 8 filings came from 6 insiders.
No insider sold shares on the market over the period. Instead, the filings list 1 purchase, made by 1 insider. No amount is published for 1 filing, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Those buying include 1 senior executive.
For context, the typical company on the same exchange (median of 1,323 companies) published 4 filings over the same period, against 8 filings here. Since 2017, the database holds 16 purchases and 18 sales by insiders of the company.
The last insider purchase was made public on 13 July 2026, 103 days ago. Filings reach the HKEX feed a median of 5 days after the trade. That lag is the time during which only the insider knows about the trade.
This summary is built from HKEX disclosures alone and does not predict where the share price will go.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
FY ended December 2025 · cache
25 of 50 declarations
United Laboratories International Holdings Ltd. is a company listed on the Hong Kong Stock Exchange, specializing in the manufacturing and distribution of pharmaceutical and healthcare products. It focuses on innovation and expanding its product portfolio.